Analysis of Revenues
Revenues as Reported
UnitedHealth Group Inc., income statement, revenues
US$ in millions
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
Revenues demonstrate consistent growth across all reported segments between 2021 and 2025. UnitedHealthcare exhibits the largest absolute revenue contribution and the most substantial overall increase during the period. Optum, as a consolidated entity, also shows significant revenue expansion, driven primarily by Optum Rx and Optum Health. Revenue from unaffiliated customers mirrors the overall growth trend, representing the largest portion of total revenue.
- UnitedHealthcare Revenue Trend
- UnitedHealthcare revenue increased from US$222,042 million in 2021 to US$342,730 million in 2025, representing a cumulative growth of approximately 54.3%. The growth rate appears relatively consistent year-over-year, with a slight acceleration observed between 2023 and 2025.
- Optum Health Revenue Trend
- Optum Health revenue grew from US$23,778 million in 2021 to US$36,869 million in 2025, a cumulative increase of approximately 54.8%. Growth was particularly strong between 2021 and 2023, with a more moderate increase from 2023 to 2025.
- Optum Insight Revenue Trend
- Optum Insight experienced growth from US$4,095 million in 2021 to US$6,369 million in 2025, representing a cumulative increase of approximately 55.3%. However, the rate of growth decelerated significantly between 2023 and 2024, and continued at a slower pace through 2025.
- Optum Rx Revenue Trend
- Optum Rx revenue increased from US$35,358 million in 2021 to US$57,679 million in 2025, a cumulative increase of approximately 63.1%. This segment demonstrated robust growth throughout the period, with the largest year-over-year increase occurring between 2023 and 2024.
- Optum Consolidated Revenue Trend
- Optum’s consolidated revenue increased from US$63,231 million in 2021 to US$100,917 million in 2025, a cumulative increase of approximately 59.6%. The growth trajectory is generally upward, with a slight deceleration in the growth rate between 2024 and 2025.
- Unaffiliated Customer Revenue Trend
- Revenues from unaffiliated customers grew from US$285,273 million in 2021 to US$443,647 million in 2025, representing a cumulative increase of approximately 55.5%. This segment consistently contributes the largest portion of overall revenue and exhibits a steady growth pattern.
Overall, the revenue performance indicates a healthy and expanding business. While all segments contribute to growth, UnitedHealthcare and Optum Rx demonstrate the most substantial increases in absolute revenue terms. The slight deceleration in growth observed in Optum Insight between 2023 and 2025 warrants further investigation.